Suchergebnisse - Restelli U

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives von Croce D, Bonfanti M, Restelli U

Volltext

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review von Silvola S, Restelli U, Bonfanti M, Croce D

Volltext

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem... von Restelli U, Croce D, Pacelli V, Ciceri F, Girmenia C

Volltext

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... von Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Volltext

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... von Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Volltext

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies... von Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Volltext

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis von Monzani R, Barbera G, Restelli U, Galeone C, Petrini F

Volltext

Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in Italy von Restelli U, Vitale J, Croce E, Bernareggi S, Guida S, Silvola S, Banfi G, Zagra L

Volltext

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... von Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Volltext

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum] von Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Volltext

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study von Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Volltext

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? von Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

Volltext

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients w... von Restelli U, Croce D, Bonizzoni E, Marzanatti M, Andreini A, Sorio M, Tecchio C, Barison E, Benedetti F

Volltext

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service von Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Volltext

The Economic Impact of Loss to Follow-Up in Eosinophilic Esophagitis: A Model-Based Analysis from the Perspective of Italian National Health Service von Bonfanti M, Fardella M, Morani M, Oliva S, Savarino EV, Giodice R, Saab JP, Castagnaro E, Tassone A, Restelli U

Volltext

Role of Inhaled Methoxyflurane in the Management of Acute Trauma Pain von Fabbri A, Ruggiano G, Garcia Collado S, Ricard-Hibon A, Restelli U, Sbrana G, Marinangeli F, Farina A, Coffey F

Volltext

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum] von Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Volltext

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey von Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Volltext

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district von Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

Volltext